InsiderTrades

Form 4 for EUDA EUDA Health Holdings Ltd

Accepted 2022-11-25 00:00:00 ET · period of report 2022-11-17 · accession 0001493152-22-033757 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-11-25 2021-11-24+ EUDA Tan Meng Dong (James) 10% J - Other — +2.78M 2.78M New —
D 2022-11-25 2021-11-24 EUDA Tan Meng Dong (James) 10% P - Purchase — +292.2K 292.2K New —
DM 2022-11-25 2021-11-24 EUDA Tan Meng Dong (James) 10% P - Purchase — +584.5K 292.2K New —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2021-11-24 J A 3,000 — 3,000 D — — (F3) The shares were transferred to Mr. Meng Dong (James) Tan from 8i Holdings 2 Pte. Ltd.
2 Common Ordinary Shares 2021-11-24 P A 292,250 — 292,250 D — — (F4) The reporting person acquired 292,250 units consisting of ordinary shares, warrants and rights at a purchase price of $10.00 per share.
3 Common Ordinary Shares 2022-11-17 J A 2,776,000 — 2,776,000 D — — (F1) The securities reported here were received from Mr. Tan's through his redemption of 8i Capital Limited's and 8i Enterprises Pte Ltd.'s holdings in Watermark Developments Limited at the closing of EUDA Health Holdings Limited's business combination with EUDA Health Limited. The total capital contribution that Mr. Tan invested was $400,000 prior to redemption.
4 Derivative Rights 2021-11-24 P A 292,250 — 292,250 D — · — to — 29,225 Ordinary shares (F4) The reporting person acquired 292,250 units consisting of ordinary shares, warrants and rights at a purchase price of $10.00 per share. (F7) The rights convert automatically into ordinary shares at the completion of the registrant's initial business combination.
5 Derivative Warrants 2021-11-24 P A 292,250 — 292,250 D $11.50 · — to — 146,125 Ordinary shares (F4) The reporting person acquired 292,250 units consisting of ordinary shares, warrants and rights at a purchase price of $10.00 per share. (F5) The warrants become exercisable on the later of (i) the completion of the registrant's initial business combination and (ii) 12 months from the closing of the registrant's initial public offering. (F6) The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC.